Navigation Links
Failure of heart drug offers lessons for drug industry

Madison, Wis. - Pfizer spent about $800 million to develop torcetrapib, a heart drug that seemed like a blockbuster until people began to die in clinical trials. Hours after learning the drug was irreversibly flawed, the company called a halt to further trials, a decision that sent its stock downward and put thousands of job......

Full article >>> elatively few useful drugs.

Tufts luck

Consider a recent study by Tufts University, which examined the cost of producing biotechnology drugs. Unlike prescription drugs that are made with synthetic chemicals, biotech drugs are derived from substances occurring naturally in the human body or in other living organisms. This is a sweet spot f......

Full article >>> at may be the first major contribution of human embryonic stem cell research. Animal tests generally work well, but tests employing stem cells and biomarkers could dramatically increase accuracy - and weed out dangerous drugs earlier.

That's not to say drugs will ever be cheap so far as consumers are concerned. The search for new medicines is a process that will continue to be costly, mai......

Full article >>>
'"/>

Source:wistechnology.com By Tom Still 12/12/06


Related biology technology :

1. Router Failure and Software Crash UW-Madison Network
2. Primary cells, rat heart endothel
3. Primary cells, rat heart muscle
4. UW tests adult stem cell role in regenerative heart care
5. InvivoSciences receives NIH grant for heart technology
6. FDA approves GEs heart-imaging technology
7. Biotech firm uses live heart tissue in drug screens
8. Aurora team implants Wisconsins first total artificial heart
9. Medical College researchers receive new grants to enhance discovery of heart-protecting anesthetics
10. UW-Madison puts heart and mind into stem cells
11. Technology helps heal heart arrhythmias in children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/27/2016)... (PRWEB) , ... April 27, 2016 , ... ... Lamka, PhD to its Scientific Advisory Board. Dr. Lamka will assist PathSensors in ... pathogen detection. , PathSensors deploys the CANARY® test platform for the detection ...
(Date:4/27/2016)... ... , ... Global Stem Cells Group and the University of Santiago ... and development initiatives for potential stem cell protocol management for 2016 – 2020. ... began meeting to establish a working agenda and foster initiatives to promote stem cell ...
(Date:4/26/2016)... Calif. (PRWEB) , ... April 27, 2016 , ... ... office of Lewis Roca Rothgerber Christie LLP as an associate in the firm’s ... U.S. and international electrical, mechanical and electromechanical patent applications. He has an electrical ...
(Date:4/26/2016)... ... April 26, 2016 , ... Heidelberg Instruments, a ... technology innovation for its Volume Pattern Generator (VPG) line of lithography systems. The ... photomasks as well as a solution for mid volume direct write lithography applications. ...
Breaking Biology Technology:
(Date:3/15/2016)... Yissum Research Development Company of the Hebrew University ... University, announced today the formation of Neteera Technologies ... biological indicators. Neteera Technologies has completed its first round ... Neteera,s ... from sweat ducts, enables reliable and speedy biometric identification, ...
(Date:3/10/2016)... 2016 --> ... "Identity and Access Management Market by Component (Provisioning, Directory ... by Organization Size, by Deployment, by Vertical, and by ... The market is estimated to grow from USD 7.20 ... at a Compound Annual Growth Rate (CAGR) of 12.2% ...
(Date:3/8/2016)... March 8, 2016   Valencell , the ... announced it has secured $11M in Series D ... a new venture fund being launched by UAE-based ... from existing investors TDF Ventures and WSJ Joshua ... continue its triple-digit growth and accelerate its pioneering ...
Breaking Biology News(10 mins):